Qin Zhou,Michelle E. Howard,Xinyi Tu,Qian Zhu,Janet M. Denbeigh,Nicholas B. Remmes,Michael G. Herman,Chris J. Beltran,Jian Yuan,Patricia T. Greipp,Judy C. Boughey,Liewei Wang,Neil Johnson,Matthew P. Goetz,Jann N. Sarkaria,Zhenkun Lou,Robert W. Mutter

Abstract:Suppl. Figures 1-5. Supplemental Figure 1. Increased engagement of resection machinery and delayed repair following proton Bragg peak-induced DNA damage. Supplemental Figure 2. DNApk inhibition does not enhance the relative efficacy of proton Bragg peak irradiation. Supplemental Figure 3. Proton Bragg peak irradiation does not enhance the relative efficacy of proton Bragg peak irradiation on XRCC4 and LIG4 deficient tumor cells. Supplemental Figure 4. LIG4 knockdown attenuates ATM inhibitor-induced RBE enhancement of Bragg peak irradiation. Supplemental Figure 5. Loss of BRCA2 and RAD51 enhances the RBE of proton Bragg peak irradiation.

Supplementary Figure S6 & Supplementary S6 Legend from Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated with Excessive DNA Damage and Replication Stress

Supplementary Table S1 from Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Figure 5 from Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma

Supplementary Figure 5 from PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Supplementary Figures from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Supplementary Figure 6 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice

Supplementary Figure 4 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Supplementary Figure S4 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Supplementary Figure Legends from Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade

Supplementary Figure 1 from Inactivation of <i>gadd45a</i> Sensitizes Epithelial Cancer Cells to Ionizing Radiation <i>in Vivo</i> Resulting in Prolonged Survival

Supplementary Figure 2 from Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma

Supplementary Figure 6 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Supplementary Figure 6 from Dysfunction of Nucleus Accumbens-1 Activates Cellular Senescence and Inhibits Tumor Cell Proliferation and Oncogenesis

Supplementary Figure 4 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice

Supplementary Figures 1-3 from Genetic Background Controls Tumor Development in <i>Pten</i>-Deficient Mice

Supplementary Figure 3 from Integrin Α6<sup>high</sup> Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Supplementary Figures 1-4 from <i>Pten</i> Inactivation Accelerates Oncogenic <i>K-ras</i>–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Figure 4 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in <i>in Vitro</i> and <i>in Vivo</i> Models of Non–Small Cell Lung Cancer

Supplementary Figure 5 from Canonical Wnt Signaling is Required for Pancreatic Carcinogenesis